Search Results - "MORA, Edna"

Refine Results
  1. 1

    Biobanking of Exosomes in the Era of Precision Medicine: Are We There Yet? by Mora, Edna M, Álvarez-Cubela, Silvia, Oltra, Elisa

    “…The emerge of personalized medicine demands high-quality human biospecimens with appropriate clinical annotation, especially in complex diseases such as…”
    Get full text
    Journal Article Book Review
  2. 2

    Targeted Gene Silencing Using RGD-Labeled Chitosan Nanoparticles by HEE DONG HAN, MANGALA, Lingegowda S, SUN JOO LEE, JU WON ROH, NICK, Alpa M, LOPEZ-BERESTEIN, Gabriel, SOOD, Anil K, JEONG WON LEE, SHAHZAD, Mian M. K, HYE SUN KIM, DEYU SHEN, EUN JI NAM, MORA, Edna M, STONE, Rebecca L, LU, Chunhua

    Published in Clinical cancer research (01-08-2010)
    “…This study aimed to develop an Arg-Gly-Asp (RGD) peptide-labeled chitosan nanoparticle (RGD-CH-NP) as a novel tumor targeted delivery system for short…”
    Get full text
    Journal Article
  3. 3

    Incidence of thyroid cancer in Puerto Rico and the US by racial/ethnic group, 2011-2015 by Tortolero-Luna, Guillermo, Torres-Cintrón, Carlos R, Alvarado-Ortiz, Mariela, Ortiz-Ortiz, Karen J, Zavala-Zegarra, Diego E, Mora-Piñero, Edna

    Published in BMC cancer (28-06-2019)
    “…Puerto Rico has the highest incidence rate of thyroid cancer (TC) in the Americas and the third highest rate worldwide. The purpose of this study was to…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    Chitosan hydrogel for localized gene silencing by Han, Hee Dong, Mora, Edna M., Roh, Ju Won, Nishimura, Masato, Lee, Sun Joo, Stone, Rebecca L., Bar-Eli, Menashe, Lopez-Berestein, Gabriel, Sood, Anil K

    Published in Cancer biology & therapy (01-05-2011)
    “…Objective: To achieve effective delivery of siRNA into target cells in vivo, we have developed a novel approach of siRNA delivery by using local drug delivery…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Biological significance of HORMA domain containing protein 1 (HORMAD1) in epithelial ovarian carcinoma by Shahzad, Mian M.K, Shin, Yong-Hyun, Matsuo, Koji, Lu, Chunhua, Nishimura, Masato, Shen, De-Yo, Kang, Yu, Hu, Wei, Mora, Edna M, Rodriguez-Aguayo, Cristian, Kapur, Arvinder, Bottsford-Miller, Justin, Lopez-Berestein, Gabriel, Rajkovic, Aleksandar, Sood, Anil K

    Published in Cancer letters (28-04-2013)
    “…Highlights ► HORMAD1 is a cancer/testis antigen expressed exclusively in germ cells during normal development. ► HORMAD1 is expressed in a substantial portion…”
    Get full text
    Journal Article
  12. 12

    Orthomolecular Oncology Review: Ascorbic Acid and Cancer 25 Years Later by González, Michael J., Miranda-Massari, Jorge R., Mora, Edna M., Guzmán, Angelik, Riordan, Neil H., Riordan, Hugh D., Casciari, Joseph J., Jackson, James A., Román-Franco, Angel

    Published in Integrative cancer therapies (01-03-2005)
    “…The effect of ascorbic acid on cancer has been a subject of great controversy. This is a follow-up review of the 1979 article by Cameron, Pauling, and…”
    Get full text
    Journal Article
  13. 13

    Intravenous vitamin C as a chemotherapy agent: a report on clinical cases by Riordan, Hugh D, Riordan, Neil H, Jackson, James A, Casciari, Joseph J, Hunninghake, Ron, González, Michael J, Mora, Edna M, Miranda-Massari, Jorge R, Rosario, Norberto, Rivera, Alfredo

    Published in Puerto Rico health sciences journal (01-06-2004)
    “…A series of seven cases are presented in which intravenous vitamin C has been used as antineoplastic agent in the treatment of different types of cancers. The…”
    Get full text
    Journal Article
  14. 14

    Intravenous ascorbic acid: protocol for its application and use by Riordan, Hugh D, Hunninghake, Ronald B, Riordan, Neil H, Jackson, James J, Meng, Xiaolong, Taylor, Paul, Casciari, Joseph J, González, Michael J, Miranda-Massari, Jorge R, Mora, Edna M, Rosario, Norberto, Rivera, Alfredo

    Published in Puerto Rico health sciences journal (01-09-2003)
    “…High dose intravenous(i.v.) ascorbic acid (AA) has been used as therapy for infectious disease from bacterial and viral origin and adjuvant therapy for cancer…”
    Get more information
    Journal Article
  15. 15

    Disability, Job Stress, the Changing Nature of Careers, and the Career Resilience Portfolio by Szymanski, Edna Mora

    Published in Rehabilitation counseling bulletin (01-06-1999)
    “…Explores implications of changes in the work environment for people with disabilities and rehabilitation counselors. Topics covered include (a) theoretical…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Inhibition of human breast carcinoma cell proliferation by ascorbate and copper by González, Michael J, Mora, Edna M, Miranda-Massari, Jorge R, Matta, Jaime, Riordan, Hugh D, Riordan, Neil H

    Published in Puerto Rico health sciences journal (01-03-2002)
    “…We tested the effect of different concentrations of ascorbic acid (AA), 50, 100, 250 mg/500 mg/dL) with copper sulfate (CS), 10 mg/dL) on human breast…”
    Get more information
    Journal Article
  18. 18

    Abstract B68: Erythropoietin stimulates ovarian tumor growth via EphB4 by Pradeep, Sunila, Huang, Jie, Mora, Edna, Wu, Sherry Y., Li, Chun, Lopez-Berestein, Gabriel, Jackson, David, Sood, Anil

    Published in Clinical cancer research (15-01-2016)
    “…Abstract Background: Recombinant human erythropoietin (rhEpo) has been widely used to treat anemia in cancer patients, concerns about its adverse effects on…”
    Get full text
    Journal Article
  19. 19

    Orthomolecular oncology: a mechanistic view of intravenous ascorbate's chemotherapeutic activity by González, Michael J, Miranda-Massari, Jorge R, Mora, Edna M, Jiménez, Ivonne Z, Matos, María Isabel, Riordan, Hugh D, Casciari, Joseph J, Riordan, Neil H, Rodríguez, Marielys, Guzmán, Angelik

    Published in Puerto Rico health sciences journal (01-03-2002)
    “…The effect of vitamin C in cancer has been a subject of great controversy; mainly because of the inconsistent results obtained by oral intakes of ascorbate…”
    Get more information
    Journal Article
  20. 20

    A Recurrent BRCA2 Mutation Explains the Majority of Hereditary Breast and Ovarian Cancer Syndrome Cases in Puerto Rico by Diaz-Zabala, Hector J, Ortiz, Ana P, Garland, Lisa, Jones, Kristine, Perez, Cynthia M, Mora, Edna, Arroyo, Nelly, Oleksyk, Taras K, Echenique, Miguel, Matta, Jaime L, Dean, Michael, Dutil, Julie

    Published in Cancers (02-11-2018)
    “…Breast cancer is the most common cause of cancer diagnosis in women and is responsible for considerable mortality among the women of Puerto Rico. However,…”
    Get full text
    Journal Article